This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stock Futures Pare Losses After Retail Sales Number

NEW YORK ( TheStreet) -- Stock futures were paring losses Monday after a rise in an April retail sales report, pointing to positive trends in U.S. growth.

Futures for the S&P 500 were off 2.25 points, or 3.15 points below fair value, to 1,627.25.

The Census Bureau reported Monday that retail sales rose 0.1% in April after falling by a revised 0.5% in March. Excluding autos, retail sales fell 0.1% after dipping 0.4%. Economists, on average, were expecting retail sales to fall 0.3% in April, and excluding autos, to dip 0.1%.

Business inventories are forecast to have increased 0.3% in March after rising 0.1% in February. The Census Bureau releases this data at 10 a.m. EDT.

Data from the world's second-largest economy was also weighing on sentiment, with China's April industrial output report rising only mildly and disappointing expectations. The modest increase in April retail sales also added to worries about a feeble economic recovery in China. The country also reported that its fixed-asset investment unexpectedly decelerated in April.

"This set of data still suggests a painfully slow mend of China's growth momentum," Yao Wei, a Hong Kong-based economist with Societe Generale SA, wrote in a report.

Carnival (CCL - Get Report) shares were shedding more than 1% to $34.72 as investors continue to digest the troubles that have hit the cruise line operator, with the latest event being two Australian passengers who went missing in the ocean after falling out the cruise ship. The search for the two was called off Friday. The company has provided assurances that its railings are more than sufficiently high to prevent accidental falls.

Elan (ELN) and Theravance (THRX) reached a $1 billion agreement in which Elan will buy 21% of royalties that Theravance receives from GlaxoSmithKline (GSK) for four respiratory drugs. Elan shares were slipping 0.34% to $11.74, while Theravance was surging more than 12% to $39.25.

The deal includes Breo Ellipta, a new treatment for chronic obstructive pulmonary disease that received approval from the Food and Drug Administration last week.

Yum! Brands (YUM - Get Report), the owner of KFC, Pizza Hut and Taco Bell said Friday that sales in China fell 29% in April, damaged by bird flu scares.

Futures for the Dow Jones Industrial Average were falling 17 points, or 25.49 points below fair value, to 15,051. Futures for the Nasdaq were down 4 points, or 5.92 points below fair value, to 2,971.5.

The Hong Kong Hang Seng Index finished down 1.42% Monday. The Nikkei 225 in Japan closed up 1.2%. The FTSE 100 in the UK was falling 0.27% and the DAX in Germany was down 0.64%.

June gold futures were down $9.40 to $1,427.20 an ounce. June oil futures were sliding $1.15 to $94.89 a barrel.

The benchmark 10-year Treasury was rising 2/32, diluting the yield to 1.897%. The dollar was up 0.04% to $83.18 according to the U.S. dollar index.

Written by Andrea Tse in New York

>To contact the writer of this article, click here: Andrea Tse.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ELN $0.00 0.00%
CCL $48.87 -0.37%
THRX $12.01 -2.67%
YUM $80.97 1.77%
AAPL $93.97 0.25%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs